Silo Pharma, Inc. (SILO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
677 N. WASHINGTON BLVD SARASOTA, FL 34236 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 7,081 | 7,665 | 11,367 | 9,837 | 1,128 | 112 | |||
| Cash and cash equivalent | 3,906 | 3,524 | 11,367 | 9,837 | 1,128 | 112 | |||
| Short-term investments | 3,175 | 4,141 | |||||||
| Receivables | 10 | 66 | 60 | 24 | 200 | ||||
| Inventory, net of allowances, customer advances and progress billings | 27 | 33 | 156 | ||||||
| Inventory | 27 | 33 | 156 | ||||||
| Prepaid expense | 1 | 108 | |||||||
| Other undisclosed current assets | 31 | 6 | 138 | 479 | 133 | 26 | |||
| Total current assets: | 7,111 | 7,681 | 11,572 | 10,402 | 1,427 | 494 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 33 | ||||||||
| Intangible assets, net (including goodwill) | 241 | ||||||||
| Intangible assets, net (excluding goodwill) | 241 | ||||||||
| Prepaid expense | 65 | 71 | 27 | ||||||
| Other noncurrent assets | 61 | ||||||||
| Other undisclosed noncurrent assets | 59 | (33) | |||||||
| Total noncurrent assets: | 300 | 65 | 71 | 88 | |||||
| TOTAL ASSETS: | 7,412 | 7,746 | 11,643 | 10,490 | 1,427 | 494 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,584 | 703 | 418 | 127 | 55 | ||||
| Accrued liabilities | 60 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 1,524 | 703 | 418 | 127 | 55 | ||||
| Deferred revenue | 72 | 72 | 72 | ||||||
| Debt | 364 | 15 | 62 | ||||||
| Due to related parties | ✕ | ✕ | ✕ | 72 | |||||
| Total current liabilities: | 1,656 | 776 | 436 | 490 | 142 | 117 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 4 | ||||||||
| Long-term debt, excluding current maturities | 4 | ||||||||
| Liabilities, other than long-term debt | 722 | 794 | 866 | 938 | |||||
| Deferred revenue | 722 | 794 | 866 | 938 | |||||
| Total noncurrent liabilities: | 722 | 794 | 866 | 938 | 4 | ||||
| Total liabilities: | 2,378 | 1,569 | 1,302 | 1,428 | 146 | 117 | |||
| Temporary equity, including noncontrolling interest | 400 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | 5,034 | 6,177 | 10,341 | 9,062 | 1,281 | (23) | |||
| Common stock | 0 | 0 | 0 | 10 | 9 | 2 | |||
| Treasury stock, value | (471) | ||||||||
| Additional paid in capital | 20,296 | 17,526 | 17,512 | 12,315 | 7,035 | 2,631 | |||
| Deferred compensation equity | (14) | ||||||||
| Accumulated other comprehensive income (loss) | 2 | (6) | |||||||
| Accumulated deficit | (15,265) | (10,872) | (7,171) | (3,263) | (5,762) | (2,656) | |||
| Other undisclosed equity, attributable to parent | 14 | ||||||||
| Total equity: | 5,034 | 6,177 | 10,341 | 9,062 | 1,281 | (23) | |||
| TOTAL LIABILITIES AND EQUITY: | 7,412 | 7,746 | 11,643 | 10,490 | 1,427 | 494 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 72 | 72 | 86 | 41 | 41 | |||
| Realized investment gains (losses) | (1) | 138 | ||||||
| Other income | 86 | 3 | ||||||
| Cost of revenue | (6) | (6) | (6) | (5) | (176) | (27) | ||
| Cost of product and service sold | (176) | (27) | ||||||
| Other undisclosed gross profit | (14) | 71 | ||||||
| Gross profit: | 66 | 66 | 66 | 66 | (135) | 13 | ||
| Operating expenses | (4,772) | (3,922) | (3,694) | (2,811) | (2,438) | (944) | ||
| Operating loss: | (4,706) | (3,856) | (3,628) | (2,744) | (2,573) | (930) | ||
| Nonoperating income (expense) | 313 | 225 | (280) | 6,926 | (465) | (83) | ||
| Investment income, nonoperating | 333 | 399 | (105) | 6,660 | 12 | 12 | ||
| Interest and debt expense | (5) | (5) | (2) | 19 | (198) | (63) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (4,398) | (3,636) | (3,910) | 4,201 | (3,235) | (1,076) | ||
| Income (loss) from equity method investments | (105) | 6,660 | ||||||
| Other undisclosed income (loss) from continuing operations before income taxes | 5 | 5 | 107 | (6,680) | ||||
| Income (loss) from continuing operations before income taxes: | (4,393) | (3,631) | (3,907) | 4,182 | (3,235) | (1,076) | ||
| Income tax expense | (25) | |||||||
| Income (loss) from continuing operations: | (4,393) | (3,631) | (3,907) | 4,157 | (3,235) | (1,076) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 3,904 | (3,235) | (1,076) | |
| Loss from discontinued operations | (70) | (1) | (253) | |||||
| Other undisclosed net income | 198 | 63 | ||||||
| Net income (loss): | (4,393) | (3,701) | (3,909) | 3,904 | (3,038) | (1,013) | ||
| Net loss attributable to noncontrolling interest | (3,909) | (3,904) | ||||||
| Other undisclosed net income attributable to parent | 3,909 | 3,904 | ||||||
| Net income (loss) attributable to parent: | (4,393) | (3,701) | (3,909) | 3,904 | (3,038) | (1,013) | ||
| Preferred stock dividends and other adjustments | (1,404) | (69) | ||||||
| Other undisclosed net income available to common stockholders, basic | 1,404 | |||||||
| Net income (loss) available to common stockholders, basic: | (4,393) | (3,701) | (3,909) | 3,904 | (3,107) | (1,013) | ||
| Other undisclosed net loss available to common stockholders, diluted | (1,404) | |||||||
| Net income (loss) available to common stockholders, diluted: | (4,393) | (3,701) | (3,909) | 2,500 | (3,107) | (1,013) | ||
Comprehensive Income ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (4,393) | (3,701) | (3,909) | 3,904 | (3,038) | (1,013) | ||
| Other comprehensive loss | (6) | |||||||
| Comprehensive income (loss): | (4,393) | (3,707) | (3,909) | 3,904 | (3,038) | (1,013) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (3,909) | (3,904) | ||||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 9 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (4,384) | (3,707) | (7,817) | (3,038) | (1,013) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.